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0010-7824/ 2020 Published by Elsevier Inc.Worldwide prevalence of IUD use is 13% (approximately 250
million women), making this technology the most widely used
form of reversible fertility control [1]. Use patterns vary consider-
ably by country/region: Sub-Saharan Africa (1%), India (1.5%), Latin
America/Caribbean (6%), Asia (excluding China, 6%), United States
(8.6%) [2], Europe (11%). In China, 41% of women use IUDs (approx-
imately 141 million users); this high prevalence in the world’s
most populated country drives global statistics. Excluding China,
global prevalence of IUD use is approximately 6%.
Regrettably, worldwide IUD use data may not result from true
contraceptive choice. In some countries, women have few options
other than IUDs, while in other countries, the IUD is scarcely avail-
able. Extreme dominance or scarcity of the IUD is likely a result of
health systems that facilitate or limit access/uptake, relative to
other options. In rare, perhaps mythical, settings where the playing
field for contraceptives is truly level, it is hoped that user prefer-
ences and not provider bias determine prevalence of use. Universal
rejection of the IUD (or any contraceptive for that matter), has
never been demonstrated in any country/setting. Ensuring choice
of a wide range of contraceptive methods, including IUDs, can help
to support reproductive justice.
Where choice is available, women select intrauterine contra-
ception over other technologies for many reasons: highly effective,
no user-actions required once initiated, long-lasting, non-contra-
ceptive benefits, among others. Some women have a choice of
either a non-hormonal IUD (containing copper) or a hormonal
(levonorgestrel-releasing) product; this major distinction often
influences many of the contraceptive decisions that women make.Intrauterine contraception has a long history of product devel-
opment, second only to condoms in terms of modern technologies.
Since the 1960s, product development went hand-in-hand with
medical science to measure safety, efficacy, and side effects. Most
novel IUDs were never marketed and only a small proportion
became commercially important. Technological innovation and
comparative research have resulted in new products replacing
old ones. Among today’s products, clinical research has unequivo-
cally demonstrated that the health benefits of modern IUDs signif-
icantly outweigh the health risks in using them. The goal of new
product development is to maintain high efficacy and safety, while
simultaneously reducing side effects to improve overall user satis-
faction; IUD side effects can lead to early removal and uptake of
less effective contraception.
The history of medical research on IUD technologies is well doc-
umented in a series of five international conferences dating back to
1962 and sponsored by the Population Council.
1. 1962: First conference, New York City, NY, USA [3]
Forty-eight participants attended this first meeting, which fea-
tured18original contributions.Numerousproductswerediscussed:
flexible oval rings made of silkworm gut, silver or stainless steel,
Marguiles polyethylene Perma-Spiral IUD, and the Lippes Loop.
Foundational statistical approaches to studying intrauterine contra-
ception were discussed by Dr. Christopher Tietze. Other topics
included radiographic techniques for imaging products in the uterus
and bacteriologic studies of the endometrium and cervix.
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The Second conference attracted over 400 participants from 38
countries (a dramatic increase from the First conference, confirm-
ing the success of the First conference in stimulating interest in the
method), with 27 papers presented and an additional 47 papers
published in the official proceedings. Topics included IUD usage
in India, Korea, and Taiwan; numerous studies on the effects of
IUD usage on the menstrual cycle, the endometrium, genital tract
infections, and other areas. Discussion sessions focused on IUD
acceptance, clinical problems, training of practitioners, placement,
size, and design of IUDs, pathology, and mechanism of action.
3. 1974: Third conference, Cairo, Egypt [5]
The preface to the proceedings from the Third conference stated
that 15 million women worldwide were using IUDs (up from ‘‘sev-
eral million” ten years earlier) and that nearly 20 different devices
were being produced commercially. The published proceedings
featured 52 original contributions under three headings: Assessing
the IUD Experience, Clinical Trials of Newer IUDs, Local and Sys-
temic Effects. The new products since the previous conference
included copper T devices, the Cu-7, the Dalkon Shield, and the
first-ever progesterone-releasing IUD. IUD mechanism of action,
menstrual bleeding changes, IUD expulsions, and pelvic inflamma-
tory disease were other key topics at this meeting.
4. 1984: Interim IUD Conference,2 Chicago, IL, USA [6]
In 1984, an IUD conference was held in Chicago. Eighty-seven
presenters covered 57 different topics, ranging from new devices
to health risks. Clinical performance of three European products
(Multiload, Nova T, and the new LNG IUS) and three varieties of
the copper T device (USA) were discussed. Governmental regula-
tory issues for IUDs were compared across countries and many
foundational clinical results were shared: endometrial changes,
bleeding, measurements of the uterine cavity, copper loss from
products, ectopic pregnancy, pelvic inflammatory disease, and
more.
5. 1994: Fourth conference: New York City, NY, USA [7]
Estimated worldwide IUD use was stated as ‘‘over 100 million”
in the introductory paper to the Fourth conference. Thirty-one
other papers in the published volume from this meeting covered
topics titled Performance of IUDs, Understanding IUDs, IUDs in
the United States, Factors Limiting IUD Use, Medical Problems
and Their Prevention, Special Issues, Designing IUD Services, and
Individual IUDs. A radically new frameless product was discussed
at the meeting: the Cu-Fix (later known as Gynefix) which consists
of copper sleeves threaded on a standard IUD string, which is
anchored into the myometrium. In terms of medical controversies
and debate, one paper at this conference summarized the concerns
of that time: ‘‘Until better data is available, we should only recom-
mend IUDs to women living in stable relationships or who have
given birth”.
6. 2006: Fifth conference: New York City, NY, USA [8]
Twenty-seven presentations were made at the Fifth conference
in 2006. Over half addressed different subtopics around the2 This meeting was not sponsored by the Population Council.levonorgestrel intrauterine system (first approved in Finland in
1990 and in the USA in 2000): use in nulliparous women, mecha-
nism of action, endometrial effects, effect on uterine leiomyomas,
menorrhagia, alternative to hysterectomy, peri- and post-meno-
pausal use, long-term use, and other subtopics. This conference
highlighted the lack of IUD uptake in the United States and the pos-
sible barriers to use. For the first time in IUD conference history, no
clinical studies of truly novel technologies (outside of China) were
discussed, indicative of the lack of European/USA investment in
research and development.7. 2020: Sixth conference: May 27–28, San Francisco, CA, USA
In 2020, scientists will convene the Sixth International Sympo-
sium on Intrauterine Devices and Systems for Women’s Health.
2020 is a time of unprecedented growth and worldwide usage of
IUDs. The meeting is intended to offer up-to-date scientific and
clinical information on many IUD topics, including emerging prod-
ucts under development and successes and challenges in providing
access to IUDs.
Papers from the first four conferences were published as mono-
graphs [3–7]. The papers from the fifth conference appeared in a
dedicated issue of Contraception in 2007 [8]. The papers from the
forthcoming sixth conference will also appear in Contraception.
Notably, 2020 marks the 50th anniversary of the first issue [9] of
the journal Contraception, created by founding editor, Daniel R.
Mishell, Jr., M.D. Mishell’s seminal contributions to IUD knowledge
and his support for IUD research are legendary. The field would not
have progressed as far without him.
With this background, we invite you to attend the upcoming
meeting in San Francisco.References
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